N D Marchenko - Concepedia

Author

N D Marchenko

Stony Brook University

Also Known As

N D Marchenko, N Marchenko, N. Marchenko, Natasha D Marchenko, Natasha D. Marchenko, Natasha Marchenko

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Stony Brook University Roche Pharma AG (Germany)University of Göttingen Technical University of Munich

About

N D Marchenko is an author at Stony Brook University specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.4K
2	Cell Biology	8	8	1.4K
3	Health Sciences	1	1	53
4	Natural Sciences	1	1	77
5	Biochemistry	1	1	77

N D Marchenko

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis Dun Li, N D Marchenko, Ute M. Moll Cell Death and Differentiation Mutant P53Tumor BiologyOncologyHdac6-hsp90 Chaperone AxisOncogenic Agent	2011	329
Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis Walter Hanel, N D Marchenko, Suheng Xu, Cell Death and Differentiation Tumor BiologyCell RegulationMedicineDifferential GainCell Proliferation	2013	286
Monoubiquitylation promotes mitochondrial p53 translocation N D Marchenko, Sonja Wolff, Susan Erster, The EMBO Journal Mitochondrial DynamicMitochondrial FunctionMitochondrial P53 TranslocationMedicineCell Biology	2007	279
WT p53, but Not Tumor-derived Mutants, Bind to Bcl2 via the DNA Binding Domain and Induce Mitochondrial Permeabilization York Tomita, N D Marchenko, Susan Erster, Journal of Biological Chemistry	2006	244
Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding N D Marchenko, Walter Hanel, Dun Li, Cell Death and Differentiation Stress-mediated Nuclear StabilizationTranscriptional RegulationCell RegulationMolecular RegulationMolecular Biology	2009	134
Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines. Sergey Y. Kovalev, N D Marchenko, Steven Swendeman, PubMed Tumor BiologyNb Cell LinesP73 GeneMedicineCancer Cell Biology	1998	131
A gain-of-function mutant p53–HSF1 feed forward circuit governs adaptation of cancer cells to proteotoxic stress Dun Li, Alisha R. Yallowitz, Lukasz S. Ozog, Cell Death and Disease Gain-of-function Mutant P53–hsf1Tumor BiologyMutant P53Cell RegulationMedicine	2014	111
HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer Rainer Schulz, Felix Streller, Andreas H. Scheel, Cell Death and Disease	2014	101
BclxL Changes Conformation upon Binding to Wild-type but Not Mutant p53 DNA Binding Domain Franz Hagn, Christian Klein, Oliver Demmer, Journal of Biological Chemistry Nmr SpectroscopyApoptosisMolecular BiologyCell DeathMolecular Genetics	2009	77
Blockade of Hsp90 by 17AAG antagonizes MDMX and synergizes with Nutlin to induce p53-mediated apoptosis in solid tumors Angelina V. Vaseva, Alisha R. Yallowitz, N D Marchenko, Cell Death and Disease	2011	55

Page 1